The pathogenesis of atherosclerosis is connected to dyslipidemia and markers of inflammation (e.g., CRP and IL-6), as well as other cytokines and adhesion molecules which affect endothelial cell activation [3,4,15]. This evidence concerns the gene IL6 and metabolic syndrome.